Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era

Frontiers in Microbiology

Volumn 6, Issue SEP, 2015, Pages

  Adland, Emily ^a   Klenerman, Paul ^b,c,d   Goulder, Philip ^a,e   Matthews, Philippa C ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d and University of Bristol   (United Kingdom)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antiretroviral therapy; CMV; Coinfection; HIV 1; Immune activation; Pediatric infectious diseases; Sub Saharan Africa

Indexed keywords

LIVE VACCINE;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPATHOLOGY; MIXED INFECTION; MORBIDITY; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); RISK FACTOR; SEROPREVALENCE; SHORT SURVEY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TRANSMISSION;

EID: 84946718107     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2015.01016     Document Type: Short Survey

References (68)

1. Adler, S. P., Starr, S. E., Plotkin, S. A., Hempfling, S. H., Buis, J., Manning, M. L., et al. (1995). Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age. J. Infect. Dis. 171, 26-32. doi: 10.1093/infdis/171.1.26
2. Alao, O. O., Mamman, A., Araoye, M. O., and Joseph, E. (2009). Effect of demographic variables on cytomegalovirus antibody seropositivity among prospective blood donors in Jos, Nigeria. Niger. Postgrad. Med. J. 16, 139-142.
3. Arvin, A. M., Fast, P., Myers, M., Plotkin, S., and Rabinovich, R. (2004). Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin. Infect. Dis. 39, 233-239. doi: 10.1086/421999
4. Ben-Smith, A., Gorak-Stolinska, P., Floyd, S., Weir, R. E., Lalor, M. K., Mvula, H., et al. (2008). Differences between naive and memory T cell phenotype in Malawian and UK adolescents: a role for Cytomegalovirus? BMC Infect. Dis. 8:139. doi: 10.1186/1471-2334-8-139
5. Böhler, T., Wintergerst, U., Linde, R., Belohradsky, B. H., and Debatin, K. M. (2001). CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Pediatr. Res. 49, 101-110. doi: 10.1203/00006450-200101000-00021
6. Brantsæter, A. B., Johannessen, A., Holberg-Petersen, M., Sandvik, L., Naman, E., Kivuyo, S. L., et al. (2012). Cytomegalovirus viremia in dried blood spots is associated with an increased risk of death in HIV-infected patients: a cohort study from rural Tanzania. Int. J. Infect. Dis. 16, e879-e885. doi: 10.1016/j.ijid.2012.08.003
7. Cannon, M. J., Schmid, D. S., and Hyde, T. B. (2010). Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20, 202-213. doi: 10.1002/rmv.655
8. Chakraborty, R., Rees, G., Bourboulia, D., Cross, A. M., Dixon, J. R., D'Agostino, A., et al. (2003). Viral coinfections among African children infected with human immunodeficiency virus type 1. Clin. Infect. Dis. 36, 922-924. doi: 10.1086/368207
9. Chakravarti, A., Tewari, S., and Bhalla, P. (2010). Human cytomegalovirus infection among patients living with AIDS in a tertiary level hospital in India. J. Int. Assoc. Phys. AIDS Care (Chic) 9, 94-97. doi: 10.1177/1545109710366180
10. Clouse, K. A., Robbins, P. B., Fernie, B., Ostrove, J. M., and Fauci, A. S. (1989). Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. J. Immunol. 143, 470-475.
11. Compston, L. I., Li, C., Sarkodie, F., Owusu-Ofori, S., Opare-Sem, O., and Allain, J. P. (2009). Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J. Med. Virol. 81, 1860-1868. doi: 10.1002/jmv.21614
12. Connick, E. (2001). Immune reconstitution in HIV-1-infected individuals treated with potent antiretroviral therapy. J. Investig. Dermatol. Symp. Proc. 6, 212-218. doi: 10.1046/j.0022-202x.2001.00049.x
13. Crough, T., and Khanna, R. (2009). Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22, 76-98. doi: 10.1128/CMR.00034-08
14. Cummins, N. W., and Badley, A. D. (2010). Mechanisms of HIV-associated lymphocyte apoptosis. Cell Death Dis. 1:e99. doi: 10.1038/cddis.2010.77
15. Dar, L., Pati, S. K., Patro, A. R., Deorari, A. K., Rai, S., Kant, S., et al. (2008). Congenital cytomegalovirus infection in a highly seropositive semi-urban population in India. Pediatr. Infect. Dis. J. 27, 841-843. doi: 10.1097/INF.0b013e3181723d55
16. Davis, M. G., Kenney, S. C., Kamine, J., Pagano, J. S., and Huang, E. S. (1987). Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 84, 8642-8646. doi: 10.1073/pnas.84.23.8642
17. Deayton, J. R., Prof Sabin, C. A., Johnson, M. A., Emery, V. C., Wilson, P., Griffiths, P. D., et al. (2004). Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363, 2116-2121. doi: 10.1016/S0140-6736(04)16500-8
18. Emery, V. C. (2014). Restimulating interest in cytomegalovirus as a cofactor for HIV infection. J. Infect. Dis. 211, 169-171. doi: 10.1093/infdis/jiu419
19. Erice, A., Tierney, C., Hirsch, M., Caliendo, A. M., Weinberg, A., Kendall, M. A., et al. (2003). Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clin. Infect. Dis. 37, 567-578. doi: 10.1086/375843
20. Erlandson, K. M., Allshouse, A. A., Rapaport, E., Palmer, B. E., Wilson, C. C., Weinberg, A., et al. (2015). Physical function impairment of older, HIV-infected adults is associated with cytomegalovirus immunoglobulin response. AIDS Res. Hum. Retroviruses 31, 905-912. doi: 10.1089/AID.2015.0085
21. Fielding, K., Koba, A., Grant, A. D., Charalambous, S., Day, J., Spak, C., et al. (2011). Cytomegalovirus viremia as a risk factor for mortality prior to antiretroviral therapy among HIV-infected gold miners in South Africa. PLoS ONE 6:e25571. doi: 10.1371/journal.pone.0025571
22. Gianella, S., Scheffler, K., Mehta, S. R., Little, S. J., Freitas, L., Morris, S. R., et al. (2015). Seminal shedding of CMV and HIV transmission among men who have sex with men. Int. J. Environ. Res. Public Health 12, 7585-7592. doi: 10.3390/ijerph120707585
23. Goussard, P., Kling, S., Gie, R. P., Nel, E. D., Heyns, L., Rossouw, G. J., et al. (2010). CMV pneumonia in HIV-infected ventilated infants. Pediatr. Pulmonol. 45, 650-655. doi: 10.1002/ppul.21228
24. Gracia-Ahufinger, I., Ferrando-Martínez, S., Montejo, M., Muñoz-Villanueva, M. C., Cantisán, S., Rivero, A., et al. (2015). Pre-transplant thymic function is associated with the risk of cytomegalovirus disease after solid organ transplantation. Clin. Microbiol. Infect. 21, 511.e1-511.e7. doi: 10.1016/j.cmi.2014.12.020
25. Griffiths, P. D., Stanton, A., McCarrell, E., Smith, C., Osman, M., Harber, M., et al. (2011). Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet 377, 1256-1263. doi: 10.1016/S0140-6736(11)60136-0
26. Griffiths, P. D. (2006). CMV as a cofactor enhancing progression of AIDS. J. Clin. Virol. 35, 489-492. doi: 10.1016/j.jcv.2005.10.016
27. Gumbo, H., Chasekwa, B., Church, J. A., Ntozini, R., Mutasa, K., Humphrey, J. H., et al. (2014). Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants. PLoS ONE 9:e114870. doi: 10.1371/journal.pone.0114870
28. Hsiao, N. Y., Zampoli, M., Morrow, B., Zar, H. J., and Hardie, D. (2013). Cytomegalovirus viraemia in HIV exposed and infected infants: prevalence and clinical utility for diagnosing CMV pneumonia. J. Clin. Virol. 58, 74-78. doi: 10.1016/j.jcv.2013.05.002
29. Itzykson, R., Robin, M., Moins-Teisserenc, H., Delord, M., Busson, M., Xhaard, A., et al. (2015). Cytomegalovirus shapes long-term immune reconstitution after allogeneic stem cell transplantation. Haematologica 100, 114-123. doi: 10.3324/haematol.2014.113415
30. Johnson, E. L., Howard, C. L., Thurman, J., Pontiff, K., Johnson, E. S., Chakraborty, R., et al. (2014). Cytomegalovirus upregulates expression of CCR5 in central memory cord blood mononuclear cells, which may facilitate in utero HIV Type 1 transmission. J. Infect. Dis. 211, 187-196. doi: 10.1093/infdis/jiu424
31. King, C. C., Ellington, S. R., and Kourtis, A. P. (2013). The role of co-infections in mother-to-child transmission of HIV. Curr. HIV Res. 11, 10-23. doi: 10.2174/1570162x11311010003
32. Kovacs, A., Schluchter, M., Easley, K., Demmler, G., Shearer, W., La Russa, P., et al. (1999). Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric pulmonary and cardiovascular complications of vertically transmitted HIV infection study group. N. Engl. J. Med. 341, 77-84. doi: 10.1056/NEJM199907083410203
33. Lanzieri, T. M., Dollard, S. C., Bialek, S. R., and Grosse, S. D. (2014). Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries. Int. J. Infect. Dis. 22, 44-48. doi: 10.1016/j.ijid.2013.12.010
34. Lichtner, M., Cicconi, P., Vita, S., Cozzi-Lepri, A., Galli, M., Lo Caputo, S., et al. (2015). Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J. Infect. Dis. 211, 178-186. doi: 10.1093/infdis/jiu417
35. Manicklal, S., Emery, V. C., Lazzarotto, T., Boppana, S. B., and Gupta, R. K. (2013). The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26, 86-102. doi: 10.1128/CMR.00062-12
36. Manicklal, S., van Niekerk, A. M., Kroon, S. M., Hutto, C., Novak, Z., Pati, S. K., et al. (2014). Birth prevalence of congenital cytomegalovirus among infants of HIV-infected women on prenatal antiretroviral prophylaxis in South Africa. Clin. Infect. Dis. 58, 1467-1472. doi: 10.1093/cid/ciu096
37. Margalith, M., D'Aquila, R. T., Manion, D. J., Basgoz, N., Bechtel, L. J., Smith, B. R., et al. (1995). HIV-1 DNA in fibroblast cultures infected with urine from HIV-seropositive cytomegalovirus (CMV) excretors. Arch. Virol. 140, 927-935.
38. Mayaphi, S. H., Brauer, M., Morobadi, D. M., Mazanderani, A. H., Mafuyeka, R. T., Olorunju, S. A., et al. (2014). Cytomegalovirus viral load kinetics in patients with HIV/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapy. PLoS ONE 9:e93702. doi: 10.1371/journal.pone.0093702
39. McKeating, J. A., Griffiths, P. D., and Weiss, R. A. (1990). HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor. Nature 343, 659-661. doi: 10.1038/343659a0
40. Micol, R., Buchy, P., Guerrier, G., Duong, V., Ferradini, L., Dousset, J. P., et al. (2009). Prevalence, risk factors, and impact on outcome of cytomegalovirus replication in serum of Cambodian HIV-infected patients (2004-2007). J. Acquir. Immune Defic. Syndr. 51, 486-491. doi: 10.1097/QAI.0b013e3181a254c2
41. Miles, D. J., Sande, M., Kaye, S., Crozier, S., Ojuola, O., Palmero, M. S., et al. (2008b). CD4(+) T cell responses to cytomegalovirus in early life: a prospective birth cohort study. J. Infect. Dis. 197, 658-662. doi: 10.1086/527418
42. Miles, D. J., Sanneh, M., Holder, B., Crozier, S., Nyamweya, S., Touray, E. S., et al. (2008). Cytomegalovirus infection induces T-cell differentiation without impairing antigen-specific responses in Gambian infants. Immunology 124, 388-400. doi: 10.1111/j.1365-2567.2007.02787.x
43. Miles, D. J., van der Sande, M., Jeffries, D., Kaye, S., Ismaili, J., Ojuola, O., et al. (2007). Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J. Virol. 81, 5766-5776. doi: 10.1128/JVI.00052-07
44. Miles, D. J., van der Sande, M., Jeffries, D., Kaye, S., Ojuola, O., Sanneh, M., et al. (2008a). Maintenance of large subpopulations of differentiated CD8 T-cells two years after cytomegalovirus infection in Gambian infants. PLoS ONE 3:e2905. doi: 10.1371/journal.pone.0002905
45. Munro, S. C., Hall, B., Whybin, L. R., Leader, L., Robertson, P., Maine, G. T., et al. (2005). Diagnosis of and screening for cytomegalovirus infection in pregnant women. J. Clin. Microbiol. 43, 4713-4718. doi: 10.1128/JCM.43.9.4713-4718.2005
46. Mwaanza, N., Chilukutu, L., Tembo, J., Kabwe, M., Musonda, K., Kapasa, M., et al. (2014). High rates of congenital cytomegalovirus infection linked with maternal HIV infection among neonatal admissions at a large referral center in sub-Saharan Africa. Clin. Infect. Dis. 58, 728-735. doi: 10.1093/cid/cit766
47. Osborn, L., Kunkel, S., and Nabel, G. J. (1989). Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U.S.A. 86, 2336-2340. doi: 10.1073/pnas.86.7.2336
48. Pass, R. F., Zhang, C., Evans, A., Simpson, T., Andrews, W., Huang, M. L., et al. (2009). Vaccine prevention of maternal cytomegalovirus infection. N. Engl. J. Med. 360, 1191-1199. doi: 10.1056/NEJMoa0804749
49. Peterson, P. K., Gekker, G., Chao, C. C., Hu, S. X., Edelman, C., Balfour, H. H. Jr., et al. (1992). Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J. Clin. Invest. 89, 574-580. doi: 10.1172/JCI115623
50. Pleskoff, O., Tréboute, C., Brelot, A., Heveker, N., Seman, M., Alizon, M., et al. (1997). Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science 276, 1874-1878. doi: 10.1126/science.276.5320.1874
51. Plotkin, S. A., Starr, S. E., Friedman, H. M., Gönczöl, E., and Weibel, R. E. (1989). Protective effects of Towne cytomegalovirus vaccine against low-passage cytomegalovirus administered as a challenge. J. Infect. Dis. 159, 860-865. doi: 10.1093/infdis/159.5.860
52. Reus, S., Portilla, J., Gimeno, A., Sánchez-Payá, J., García-Henarejos, J. A., Martínez-Madrid, O., et al. (2004). [Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy]. Enferm. Infecc. Microbiol. Clin. 22, 142-149. doi: 10.1016/S0213-005X(04)73054-2
53. Riou, C., Tanko, R. F., Soares, A. P., Masson, L., Werner, L., Garrett, N. J., et al. (2015). Restoration of CD4+ responses to Copathogens in HIV-infected individuals on antiretroviral therapy is dependent on T cell memory phenotype. J. Immunol. 195, 2273-2281. doi: 10.4049/jimmunol.1500803
54. Roxby, A. C., Atkinson, C., Asbjornsdottir, K., Farquhar, C., Kiarie, J. N., Drake, A. L., et al. (2014). Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women. PLoS ONE 9:e87855. doi: 10.1371/journal.pone.0087855
55. Schaftenaar, E., Verjans, G. M., Getu, S., McIntyre, J. A., Struthers, H. E., Osterhaus, A. D., et al. (2014). High seroprevalence of human herpesviruses in HIV-infected individuals attending primary healthcare facilities in rural South Africa. PLoS ONE 9:e99243. doi: 10.1371/journal.pone.0099243
56. Schlesinger, Y., Reich, D., Eidelman, A. I., Schimmel, M. S., Hassanin, J., Miron, D., et al. (2005). Congenital cytomegalovirus infection in Israel: screening in different subpopulations. Isr. Med. Assoc. J. 7, 237-240.
57. Silvestri, G., Munoz-Calleja, C., Bagnarelli, P., Piedimonte, G., Clementi, M., Montroni, M., et al. (1998). Early increase of CD4+ CD45RA+ and CD4+ CD95-cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients. Clin. Exp. Immunol. 111, 3-11. doi: 10.1046/j.1365-2249.1998.00464.x
58. Sloand, E. M., Young, N. S., Kumar, P., Weichold, F. F., Sato, T., Maciejewski, J. P., et al. (1997). Role of Fas ligand and receptor in the mechanism of T-cell depletion in acquired immunodeficiency syndrome: effect on CD4+ lymphocyte depletion and human immunodeficiency virus replication. Blood 89, 1357-1363.
59. Slyker, J. A., Lohman-Payne, B. L., Rowland-Jones, S. L., Otieno, P., Maleche-Obimbo, E., Richardson, B., et al. (2009). The detection of cytomegalovirus DNA in maternal plasma is associated with mortality in HIV-1-infected women and their infants. AIDS 23, 117-124. doi: 10.1097/QAD.0b013e32831c8abd
60. Slyker, J. A., Rowland-Jones, S. L., Dong, T., Reilly, M., Richardson, B., Emery, V. C., et al. (2012). Acute cytomegalovirus infection is associated with increased frequencies of activated and apoptosis-vulnerable T cells in HIV-1-infected infants. J. Virol. 86, 11373-11379. doi: 10.1128/JVI.00790-12
61. Stevens, D. R., Sawinski, D., Blumberg, E., Galanakis, N., Bloom, R. D., and Trofe-Clark, J. (2015). Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis. Trans. Infect. Dis. 17, 163-173. doi: 10.1111/tid.12349
62. Tembo, J., Kabwe, M., Chilukutu, L., Chilufya, M., Mwaanza, N., Chabala, C., et al. (2015). Prevalence and risk factors for Betaherpesvirus DNAemia in Children >3 Weeks and <2 Years of age admitted to a large Referral Hospital in Sub-Saharan Africa. Clin. Infect. Dis. 60, 423-431. doi: 10.1093/cid/ciu853
63. van der Sande, M. A., Kaye, S., Miles, D. J., Waight, P., Jeffries, D. J., Ojuola, O. O., et al. (2007). Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS ONE 2:e492. doi: 10.1371/journal.pone.0000492
64. Viljoen, J., Tuaillon, E., Nagot, N., Danaviah, S., Peries, M., Padayachee, P., et al. (2015). Cytomegalovirus, and possibly Epstein-Barr virus, shedding in breast milk is associated with HIV-1 transmission by breastfeeding. AIDS 29, 145-153. doi: 10.1097/QAD.0000000000000527
65. Wang, D., and Fu, T. M. (2014). Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease. Curr. Opin. Virol. 6, 13-23. doi: 10.1016/j.coviro.2014.02.004
66. Webster, A., Grundy, J. E., Lee, C. A., Emery, V. C., Cook, D. G., Kernoff, P. B., et al. (1989). Cytomegalovirus infection and progression to AIDS. Lancet 2, 681. doi: 10.1016/S0140-6736(89)90928-8
67. Wohl, D. A., Zeng, D., Stewart, P., Glomb, N., Alcorn, T., Jones, S., et al. (2005). Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies. J. Acquir. Immune Defic. Syndr. 38, 538-544. doi: 10.1097/01.qai.0000155204.96973.c3
68. Zhang, X. W., Li, F., Yu, X. W., Shi, X. W., Shi, J., Zhang, J. P., et al. (2007). Physical and intellectual development in children with asymptomatic congenital cytomegalovirus infection: a longitudinal cohort study in Qinba mountain area, China. J. Clin. Virol. 40, 180-185. doi: 10.1016/j.jcv.2007.08.018